artemisinin trioxane dimers (Artemisia BioMedical)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameartemisinin trioxane dimers (Artemisia BioMedical)
Drug Alias NameART dimers (Artemisia BioMedical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRadical donator
TargetsUpdating
Therapy Area/IndicationsInflammationNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArtemisia BioMedical IncJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasmsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A